MAM
EMPIRE STATE BUILDING LAUNCHES #HEROESSHINEBRIGHT CAMPAIGN TO THANK FIRST RESPONDERS
The Empire State Building (ESB) today announced the launch of #HeroesShineBright, a weeklong campaign to thank every person putting their lives on the line to save others during the COVID-19 pandemic both in the United States and around the world. Every night from April 24 through May 2, ESB will dedicate its tower lights to a different First Responder organization, shining in their representative colors to acknowledge their bravery and service.
On May 2, the final night of #HeroesShineBright, ESB will partner with the World Federation of Great Towers in a coordinated lighting that will see the Burj Khalifa (UAE), CN Tower (Canada), Macau Tower (China), Busan Tower (South Korea), Willis Tower (US), Euromast (Netherlands), 360 Chicago (US), Calgary Tower (Canada), One Liberty Observation Deck (US), Ostankino TV Tower (Russia), Tallinn TV Tower (Estonia), UFO Tower (Slovakia), and others shine their lights in a red heartbeat from 8:30 – 9:30 p.m. in their local time zone to bring global awareness to those helping fight the pandemic. The Eiffel Tower will also dedicate its signature sparkle to the campaign that evening.
The schedule of lightings is as follows: (Catch live in India at IST 6 a.m. to 7 a.m.)
· April 24 Yellow/White/Blue w/ Siren Effect in honor of
FDNY/EMS
· April 25 Blue/White/Blue in honor of Doctors, Nurses and the Medical
Community
· April 26 Blue/Orange/Blue in honor of Correction Officers
· April 27 Split lights:
· North & South: Orange/Blue/White in honor of the U.S. Coast Guard
· East & West: Blue/Gold/Blue in honor of the U.S. Navy
· April 28 Yellow/Black/White in honor of the U.S. Army
· April 29 Blue/Blue/Blue in honor of the Metropolitan Transportation Authority
· April 30 Yellow/Yellow/Yellow in honor of Essential Workers
· May 1 Blue/Purple/Blue in honor of Police Memorial Day
· May 2 Dynamic heartbeat lighting in coordination with the World Federation of Great
Towers
“The Empire State Building is the beating heart of all of us, and the international icon of the skyline of New York City. She shines her lights to show First Responders and essential workers our appreciation, love, and support, which they deserve,” said Anthony E. Malkin, Chairman and CEO of Empire State Realty Trust. “Our tribute to the heroes on the front lines of our great city, one group at a time, will culminate with a worldwide show of support as the World Federation of Great Towers showers universal light to spotlight the contributions of First Responders around the world.”
The Empire State Building encourages fans to participate in the #HeroesShineBright campaign, and leave comments on its posts and stories across its social media platforms thanking essential workers each night of the lightings. On May 2, the Building will share a celebratory compilation video incorporating videos of personal thank yous, fan comments, and inspiring videos of the lightings across the globe.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
